Dräger drug screening machines earn top performance ratings from the National Highway Traffic Safety Administration


HOUSTON – Dräger, an international leader in medical technology and safety, is proud to announce that the Dräger DrugTest 5000 (DDT5000) and the Dräger DrugCheck 3000 (DDC3000) have received top ratings for overall performance in a National Highway Traffic Safety Administration (NHTSA) and Governors Highway Safety Association (GHSA) assessment report. The GHSA Board of Directors approved the use of research funding from the National Cooperative Research and Evaluation Program for NHTSA to evaluate portable oral drug testing devices in a laboratory environment control.

The objective of the report, “Evaluation of On-Site Oral Drug Testing Technology”, was to evaluate oral drug field test devices to assess their accuracy, reliability, performance. compared to the manufacturer’s specifications, their sensitivity to interference and the consumables’ resistance to extremes. temperature and humidity.

Two previous studies that tested oral fluid testing devices were used to determine the testing scope and cutoff concentrations for the assessment of NHTSA. “The Roadside Testing Assessment” (ROSITA), which recommends sensitivity and specificity greater than 90% and precision greater than 95%, and the “Driving Under the Influence of Drugs, Alcohol and Medicines” (DRUID) project, which recommends more than 80% of sensitivity, specificity and precision. The Dräger DDT5000 and DDC3000 were the only devices that met the performance requirements of ROSITA and DRUID.

“Dräger’s mission is technology for life, and we are proud to have recognition for our oral fluid technology by NHTSA and GHSA, organizations whose missions are to keep people safe on the road. American, ”said John Wilson, senior vice president of sales and marketing at Dräger. for security solutions in North America. “Since 1889, Dräger products have protected, supported and saved lives. We continue this legacy by providing tools that help law enforcement agencies better understand impaired driving investigations.

For more information on Dräger law enforcement solutions, visit http://t4.life/Lb2.

Dräger. Technology for life®

Dräger is an international leader in the fields of medical technology and safety. Our products protect, support and save lives. Founded in 1889, Dräger generated sales of approximately 3.4 billion euros in 2020. The Dräger Group is currently present in more than 190 countries and has more than 15,000 employees worldwide. Please visit www.draeger.com for more information.


Comments are closed.